Valneva SE (VALN) Enterprise Value (2021 - 2026)
Valneva SE (VALN) posted Enterprise Value of -$123.2 million for Q1 2026, up 3.45% sequentially from -$127.6 million in Q4 2025, and up 23.42% YoY from -$99.9 million in Q1 2025.
Analysis
Valneva SE (VALN) Enterprise Value (2021 - 2026) Analysis & Trends
Valneva SE has reported Enterprise Value for 8 years, with the latest figure at -$123.2 million in Q1 2026.
- Quarterly Enterprise Value rose 23.42% year-over-year to -$123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$123.2 million (up 23.42% YoY) and the FY2025 annual result came in at -$127.6 million, up 30.44% from the prior year.
- Enterprise Value advanced to -$123.2 million in Q1 2026 per VALN's latest filing, from -$127.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$123.2 million in Q1 2026 and troughed at -$358.8 million in Q2 2022.
- A 5-year average of -$207.7 million and a median of -$184.1 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 638756.95% in 2022, then jumped 53.6% in 2023.
- Over 5 years, Enterprise Value stood at -$292.3 million in 2022, then surged by 53.6% to -$135.7 million in 2023, then slumped by 33.54% to -$181.2 million in 2024, then advanced by 29.54% to -$127.6 million in 2025, then climbed by 3.45% to -$123.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$123.2 million, -$127.6 million, and -$167.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 312.55 Mn |
| Mar 31, 2026 | 419.07 Mn |
| Dec 31, 2025 | 637.67 Mn |
| Sep 30, 2025 | 823.67 Mn |
| Jun 30, 2025 | 227.36 Mn |
| Mar 31, 2025 | 384.33 Mn |
| Dec 31, 2024 | 123.46 Mn |
| Sep 30, 2024 | 247.82 Mn |
| Jun 30, 2024 | 345.37 Mn |
| Mar 31, 2024 | 358.20 Mn |
| Dec 31, 2023 | 522.12 Mn |
| Sep 30, 2023 | 614.72 Mn |
| Jun 30, 2023 | 731.63 Mn |
| Mar 31, 2023 | 435.98 Mn |
| Dec 31, 2022 | 515.87 Mn |
| Sep 30, 2022 | 268.01 Mn |
| Jun 30, 2022 | 835.14 Mn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 2.92 Bn |
| Sep 30, 2021 | 1.13 Bn |